Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs
- PMID: 26575359
- DOI: 10.1056/NEJMe1513245
Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs
Comment on
-
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.N Engl J Med. 2015 Dec 31;373(27):2618-28. doi: 10.1056/NEJMoa1512614. Epub 2015 Nov 16. N Engl J Med. 2015. PMID: 26569658 Clinical Trial.
-
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.N Engl J Med. 2015 Dec 31;373(27):2599-607. doi: 10.1056/NEJMoa1512610. Epub 2015 Nov 16. N Engl J Med. 2015. PMID: 26571066 Clinical Trial.
-
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.N Engl J Med. 2015 Dec 31;373(27):2608-17. doi: 10.1056/NEJMoa1512612. Epub 2015 Nov 17. N Engl J Med. 2015. PMID: 26575258 Clinical Trial.
Similar articles
-
Sofosbuvir and Velpatasvir for Patients with HCV Infection.N Engl J Med. 2016 Apr 28;374(17):1688-9. doi: 10.1056/NEJMc1601160. N Engl J Med. 2016. PMID: 27135095 No abstract available.
-
Sofosbuvir and Velpatasvir for Patients with HCV Infection.N Engl J Med. 2016 Apr 28;374(17):1688. doi: 10.1056/NEJMc1601160. N Engl J Med. 2016. PMID: 27135094 No abstract available.
-
Sofosbuvir and Velpatasvir for Patients with HCV Infection.N Engl J Med. 2016 Apr 28;374(17):1687. doi: 10.1056/NEJMc1601160. N Engl J Med. 2016. PMID: 27119243 No abstract available.
-
A pangenotypic, single tablet regimen of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection.Expert Opin Pharmacother. 2017 Apr;18(5):535-543. doi: 10.1080/14656566.2017.1282459. Epub 2017 Mar 24. Expert Opin Pharmacother. 2017. PMID: 28092171 Review.
-
Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure.Drug Des Devel Ther. 2017 Feb 23;11:497-502. doi: 10.2147/DDDT.S130945. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28260862 Free PMC article. Review.
Cited by
-
Effectiveness of generic sofosbuvir in the treatment of chronic hepatitis C virus infection in Saudi patients.Saudi Med J. 2023 Dec;44(12):1240-1247. doi: 10.15537/smj.2023.44.12.20230481. Saudi Med J. 2023. PMID: 38016752 Free PMC article.
-
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.JAMA Netw Open. 2022 Dec 1;5(12):e2246604. doi: 10.1001/jamanetworkopen.2022.46604. JAMA Netw Open. 2022. PMID: 36515952 Free PMC article.
-
Social Networks, Stigma, and Hepatitis C Care Among Women Who Inject Drugs: Findings from A Community Recruited Sample.J Psychoactive Drugs. 2023 Sep-Oct;55(4):464-470. doi: 10.1080/02791072.2022.2129886. Epub 2022 Dec 1. J Psychoactive Drugs. 2023. PMID: 36453686 Free PMC article.
-
The effect of hepatitis C-associated premature deaths on labour productivity losses in Spain: a ten-year analysis.Eur J Health Econ. 2023 Nov;24(8):1271-1283. doi: 10.1007/s10198-022-01540-z. Epub 2022 Nov 10. Eur J Health Econ. 2023. PMID: 36352296 Free PMC article.
-
Estimating the causal effect of treatment with direct-acting antivirals on kidney function among individuals with hepatitis C virus infection.PLoS One. 2022 May 13;17(5):e0268478. doi: 10.1371/journal.pone.0268478. eCollection 2022. PLoS One. 2022. PMID: 35560032 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources